This company has been marked as potentially delisted and may not be actively trading. Prometheus Biosciences (RXDX) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock RXDX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period EQS-News: Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to AbivaxNovember 14, 2024 | markets.businessinsider.comAbivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to AbivaxNovember 14, 2024 | markets.businessinsider.comCormorant Private Healthcare Fund III LP's Net WorthMarch 6, 2024 | benzinga.comHarbor Capital Advisors Inc. Takes $225,000 Position in Prometheus Biosciences, Inc. (NASDAQ:RXDX)July 13, 2023 | marketbeat.comPrometheus Biosciences, Inc. (NASDAQ:RXDX) Receives Consensus Recommendation of "Hold" from AnalystsJuly 11, 2023 | marketbeat.comVictory Capital Management Inc. Boosts Holdings in Prometheus Biosciences, Inc. (NASDAQ:RXDX)June 24, 2023 | marketbeat.comWaypoint Capital Advisors LLC Sells 16,715 Shares of Prometheus Biosciences, Inc. (NASDAQ:RXDX)June 23, 2023 | marketbeat.comPrometheus Biosciences (Nasdaq:RXDX) HeadlineTrading was temporarily halted for "RXDX" at 07:06 PM with a stated reason of "News pending."...June 16, 2023 | marketbeat.comPrometheus Biosciences, Inc. (NASDAQ:RXDX) Receives Average Rating of "Hold" from AnalystsJune 16, 2023 | marketbeat.comFred Alger Management LLC Purchases 323,091 Shares of Prometheus Biosciences, Inc. (NASDAQ:RXDX)June 14, 2023 | marketbeat.comMoran Wealth Management LLC Purchases New Holdings in Prometheus Biosciences, Inc. (NASDAQ:RXDX)June 11, 2023 | marketbeat.comDriehaus Capital Management LLC Takes Position in Prometheus Biosciences, Inc. (NASDAQ:RXDX)June 9, 2023 | marketbeat.comPlatinum Investment Management Ltd. Lowers Stock Position in Prometheus Biosciences, Inc. (NASDAQ:RXDX)June 8, 2023 | marketbeat.comAmerican International Group Inc. Purchases 1,925 Shares of Prometheus Biosciences, Inc. (NASDAQ:RXDX)June 7, 2023 | marketbeat.comPrometheus Biosciences, Inc. (NASDAQ:RXDX) Position Increased by Principal Financial Group Inc.June 4, 2023 | marketbeat.comUBS Group AG Buys 31,951 Shares of Prometheus Biosciences, Inc. (NASDAQ:RXDX)May 31, 2023 | marketbeat.comPrometheus Biosciences: 8.5% IRR And Closing In A MonthMay 30, 2023 | seekingalpha.comPrometheus Biosciences (NASDAQ: RXDX)May 28, 2023 | fool.comEnvestnet Asset Management Inc. Acquires 3,175 Shares of Prometheus Biosciences, Inc. (NASDAQ:RXDX)May 26, 2023 | marketbeat.comFirst Trust Advisors LP Acquires 26,916 Shares of Prometheus Biosciences, Inc. (NASDAQ:RXDX)May 24, 2023 | marketbeat.comPrometheus Biosciences gains after HSR waiting for sale to Merck expiresMay 23, 2023 | msn.comSHAREHOLDER ALERT: Weiss Law Investigates Prometheus Biosciences, Inc.May 23, 2023 | barrons.comSectoral Asset Management Inc. Purchases 9,000 Shares of Prometheus Biosciences, Inc. (NASDAQ:RXDX)May 22, 2023 | marketbeat.comPrometheus Biosciences, Inc. (NASDAQ:RXDX) Receives Consensus Rating of "Hold" from BrokeragesMay 22, 2023 | marketbeat.comWhat Makes Prometheus Biosciences (RXDX) an Attractive Investment Choice?May 18, 2023 | finance.yahoo.comJennison Associates LLC Purchases New Position in Prometheus Biosciences, Inc. (NASDAQ:RXDX)May 17, 2023 | marketbeat.comState Board of Administration of Florida Retirement System Reduces Stake in Prometheus Biosciences, Inc. (NASDAQ:RXDX)May 16, 2023 | marketbeat.comPrometheus Biosciences, Inc. (RXDX) is a Great Momentum Stock: Should You Buy?May 12, 2023 | finance.yahoo.comJefferies Downgrades Prometheus Biosciences (RXDX)May 11, 2023 | msn.comRBC Capital Maintains Prometheus Biosciences (RXDX) Sector Perform RecommendationMay 11, 2023 | msn.comPrometheus Biosciences (NASDAQ:RXDX) Stock Rating Lowered by Jefferies Financial GroupMay 10, 2023 | marketbeat.comPrometheus Biosciences Reports First Quarter 2023 Financial Results and Highlights Recent Corporate ProgressMay 9, 2023 | yahoo.comAbbvie, Bristol Myers competed with Merck in sale of Prometheus - reportMay 1, 2023 | msn.comWith 67% ownership, Prometheus Biosciences, Inc. (NASDAQ:RXDX) boasts of strong institutional backingApril 29, 2023 | finance.yahoo.comIeq Capital LLC Cuts Stock Position in Prometheus Biosciences, Inc. (NASDAQ:RXDX)April 28, 2023 | marketbeat.comSG Americas Securities LLC Boosts Stake in Prometheus Biosciences, Inc. (NASDAQ:RXDX)April 27, 2023 | marketbeat.comPrometheus Biosciences, Inc. (NASDAQ:RXDX) Given Consensus Rating of "Hold" by BrokeragesApril 27, 2023 | marketbeat.comNew York State Common Retirement Fund Lowers Stock Holdings in Prometheus Biosciences, Inc. (NASDAQ:RXDX)April 25, 2023 | marketbeat.comPharma Stock Roundup: JNJ Beats on Q1 Earnings, MRK to Buy RXDX & Other UpdatesApril 21, 2023 | finance.yahoo.comStrs Ohio Sells 4,700 Shares of Prometheus Biosciences, Inc. (NASDAQ:RXDX)April 21, 2023 | marketbeat.comWhy Prometheus Biosciences Stock Is Skyrocketing This WeekApril 20, 2023 | finance.yahoo.comRBC Capital downgrades Prometheus Biosciences (RXDX) to a HoldApril 18, 2023 | markets.businessinsider.comPrometheus Biosciences, Inc. (RXDX) Stock Jumps 69.7%: Will It Continue to Soar?April 18, 2023 | finance.yahoo.comHow to Tell Biotech’s Likely Winners From LosersApril 18, 2023 | finance.yahoo.comLooking At Prometheus Biosciences's Recent Unusual Options ActivityApril 17, 2023 | benzinga.comSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Prometheus Biosciences, Inc. (RXDX)April 17, 2023 | markets.businessinsider.comPrometheus (RXDX) Stock Surges 70% on Buyout Offer From MerckApril 17, 2023 | finance.yahoo.comMerck’s Deal for Prometheus Expected to Generate Billions in Additional SalesApril 17, 2023 | barrons.comMerck Acquires Prometheus Biosciences for $10.8 BillionApril 17, 2023 | msn.comMerck/Prometheus: Big Pharma must swallow bigger premiumsApril 17, 2023 | finance.yahoo.com Get Prometheus Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RXDX and its competitors with MarketBeat's FREE daily newsletter. Email Address RXDX Media Mentions By Week RXDX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RXDX News Sentiment▼0.770.38▲Average Medical News Sentiment RXDX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RXDX Articles This Week▼00▲RXDX Articles Average Week Get Prometheus Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RXDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HYPD News PHXM News ADIL News SXTPW News DRTSW News BCTXW News ENGNW News FBIOP News GOVXW News JSPRW News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RXDX) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prometheus Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Prometheus Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
